telmisartan sold brand name micardis among others medication used treat high blood pressure heart failure diabetic kidney reasonable initial treatment high blood taken versions available telmisartanhydrochlorothiazide common side effects include upper respiratory tract infections diarrhea back serious side effects may include kidney problems low blood pressure use pregnancy may harm baby use breastfeeding angiotensin ii receptor antagonist works blocking effects angiotensin telmisartan patented came medical use available generic commonly prescribed medication united states million telmisartan used treat high blood pressure heart failure diabetic kidney reasonable initial treatment high blood telmisartan contraindicated pregnancy like drugs affecting system ras telmisartan cause birth defects stillbirths neonatal deaths known whether drug passes breast also contraindicated bilateral renal artery stenosis cause kidney failure side effects similar angiotensin ii receptor antagonists include tachycardia bradycardia fast slow heartbeat hypotension low blood pressure edema swelling arms legs lips tongue throat latter leading breathing problems allergic reactions may also due mechanism action telmisartan increases blood potassium levels combination potassium preparations potassiumsparing diuretics could cause hyperkalaemia excessive potassium levels combination nsaids especially patients impaired kidney function risk causing usually reversible kidney telmisartan angiotensin ii receptor blocker shows high affinity angiotensin ii receptor type binding affinity times greater addition blocking system telmisartan acts selective modulator peroxisome proliferatoractivated receptor gamma pparγ central regulator insulin glucose metabolism believed telmisartans dual mode action may provide protective benefits vascular renal damage caused diabetes cardiovascular disease telmisartans activity peroxisome proliferatoractivated receptor delta pparδ receptor prompted speculation around potential sport doping agent alternative gw telmisartan activates pparδ receptors several also telmisartan pparγ agonist substance quickly varying degrees absorbed gut average bioavailability food intake clinically relevant influence kinetics telmisartan plasma protein binding mainly albumin longest halflife angiotensin ii receptor blocker arb largest volume distribution among arbs less telmisartan inactivated glucuronidation liver eliminated unchanged form via bile telmisartan available generic httpsenwikipediaorgwikitelmisartan